RBC Capital Mkts initiated coverage on SOPHiA GENETICS SA with a new price target
$SOPH
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
RBC Capital Mkts initiated coverage of SOPHiA GENETICS SA with a rating of Outperform and set a new price target of $8.00